For example, plasma metabolic profiles, obtained using 1H-NMR, differentiated patients with different RA disease activity and showed treatment with TNF-α inhibitors modified the baseline metabolic profiles associated with active RA to resemble those of patients in remission [16]. The gene discussed is TNF; the disease is rheumatoid arthritis.